 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/08/2026 |
$321.91 |
$326.63 |
$311.73 |
$314.88 |
405.00K | | 07/09/2026 |
$320.08 |
$323.33 |
$315.02 |
$322.61 |
583.10K | | 07/10/2026 |
$322.23 |
$322.81 |
$310.67 |
$316.24 |
148.60K | | 07/13/2026 |
$315.09 |
$316.42 |
$304.77 |
$309.25 |
245.70K | | 07/14/2026 |
$309.25 |
$309.25 |
$300.00 |
$300.97 |
649.10K |
 |
| Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. Co. does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several U.S. Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso. | |
 |

Ligand Pharmaceuticals (LGND) has the following price history information. Looking back at LGND historical stock prices for the last five trading days, on July 08, 2026, LGND opened at $321.91, traded as high as $326.63 and as low as $311.73, and closed at $314.88. Trading volume was a total of 405.00K shares. On July 09, 2026, LGND opened at $320.08, traded as high as $323.33 and as low as $315.02, and closed at $322.61. Trading volume was a total of 583.10K shares. On July 10, 2026, LGND opened at $322.23, traded as high as $322.81 and as low as $310.67, and closed at $316.24. Trading volume was a total of 148.60K shares. On July 13, 2026, LGND opened at $315.09, traded as high as $316.42 and as low as $304.77, and closed at $309.25. Trading volume was a total of 245.70K shares. On July 14, 2026, LGND opened at $309.25, traded as high as $309.25 and as low as $300.00, and closed at $300.97. Trading volume was a total of 649.10K shares.
LGND Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ligand Pharmaceuticals shares, starting with a $10,000 purchase of LGND, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/15/2016 |
|
| End date: |
07/14/2026 |
|
| Start price/share: |
$78.62 |
|
| End price/share: |
$300.97 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
282.82% |
|
| Average Annual Total Return: |
14.36% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$38,273.76 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 07/08/2026 | $314.88 | | 07/09/2026 | $322.61 | | 07/10/2026 | $316.24 | | 07/13/2026 | $309.25 | | 07/14/2026 | $300.97 |
|
 |